Jeffrey C. Way

8.6k total citations · 3 hit papers
84 papers, 6.4k citations indexed

About

Jeffrey C. Way is a scholar working on Molecular Biology, Genetics and Ecology. According to data from OpenAlex, Jeffrey C. Way has authored 84 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 19 papers in Genetics and 11 papers in Ecology. Recurrent topics in Jeffrey C. Way's work include CRISPR and Genetic Engineering (24 papers), Microbial Metabolic Engineering and Bioproduction (16 papers) and Bacterial Genetics and Biotechnology (14 papers). Jeffrey C. Way is often cited by papers focused on CRISPR and Genetic Engineering (24 papers), Microbial Metabolic Engineering and Bioproduction (16 papers) and Bacterial Genetics and Biotechnology (14 papers). Jeffrey C. Way collaborates with scholars based in United States, Netherlands and Canada. Jeffrey C. Way's co-authors include Pamela A. Silver, Martin Chalfie, Daniel C. Ducat, Nancy Kleckner, Donald Morisato, Michael A. Davis, Denise E. Roberts, S. Jordan Kerns, J. Abraham Avelar‐Rivas and Jonathan W. Kotula and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Jeffrey C. Way

84 papers receiving 6.3k citations

Hit Papers

New Tn10 derivatives for transposon mutagenesis and for c... 1984 2026 1998 2012 1984 1988 1989 100 200 300 400 500

Peers

Jeffrey C. Way
Lei Young Australia
Ray-Yuan Chuang United States
Daniel G. Gibson United States
Michael Krause United States
Sang‐Tae Kim South Korea
Gary C. Hon United States
Junho Lee South Korea
David Hirsh United States
Lei Young Australia
Jeffrey C. Way
Citations per year, relative to Jeffrey C. Way Jeffrey C. Way (= 1×) peers Lei Young

Countries citing papers authored by Jeffrey C. Way

Since Specialization
Citations

This map shows the geographic impact of Jeffrey C. Way's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey C. Way with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey C. Way more than expected).

Fields of papers citing papers by Jeffrey C. Way

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey C. Way. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey C. Way. The network helps show where Jeffrey C. Way may publish in the future.

Co-authorship network of co-authors of Jeffrey C. Way

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey C. Way. A scholar is included among the top collaborators of Jeffrey C. Way based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey C. Way. Jeffrey C. Way is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yocum, R. Rogers, et al.. (2023). High spontaneous integration rates of end-modified linear DNAs upon mammalian cell transfection. Scientific Reports. 13(1). 6835–6835. 10 indexed citations
2.
Veling, Mike T., Dan T. Nguyen, Nicole N. Thadani, et al.. (2022). Natural and Designed Proteins Inspired by Extremotolerant Organisms Can Form Condensates and Attenuate Apoptosis in Human Cells. ACS Synthetic Biology. 11(3). 1292–1302. 11 indexed citations
3.
Vernet, Andyna, et al.. (2021). Rational engineering of an erythropoietin fusion protein to treat hypoxia. Protein Engineering Design and Selection. 34. 3 indexed citations
4.
Hsu, Bryan B., Jeffrey C. Way, & Pamela A. Silver. (2020). Stable Neutralization of a Virulence Factor in Bacteria Using Temperate Phage in the Mammalian Gut. mSystems. 5(1). 54 indexed citations
5.
Nangle, Shannon N., Mara C. Inniss, Matthew J. Niederhuber, et al.. (2019). Synthetic Gene Circuits Enable Systems-Level Biosensor Trigger Discovery at the Host-Microbe Interface. mSystems. 4(4). 35 indexed citations
6.
Wyche, Thomas P., et al.. (2018). Mammalian Cells Engineered To Produce New Steroids. ChemBioChem. 19(17). 1827–1833. 1 indexed citations
7.
Riglar, David T., Tobias W. Giessen, Michael Baym, et al.. (2017). Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation. Nature Biotechnology. 35(7). 653–658. 275 indexed citations
8.
Chen, Jan‐Hung, et al.. (2014). Designing Cell-Targeted Therapeutic Proteins Reveals the Interplay between Domain Connectivity and Cell Binding. Biophysical Journal. 107(10). 2456–2466. 6 indexed citations
9.
Ducat, Daniel C., J. Abraham Avelar‐Rivas, Jeffrey C. Way, & Pamela A. Silver. (2012). Rerouting Carbon Flux To Enhance Photosynthetic Productivity. Applied and Environmental Microbiology. 78(8). 2660–2668. 267 indexed citations
10.
Ducat, Daniel C., Jeffrey C. Way, & Pamela A. Silver. (2011). Engineering cyanobacteria to generate high-value products. Trends in biotechnology. 29(2). 95–103. 366 indexed citations
11.
Niederholtmeyer, Henrike, Bernd T. Wolfstädter, David F. Savage, Pamela A. Silver, & Jeffrey C. Way. (2010). Engineering Cyanobacteria To Synthesize and Export Hydrophilic Products. Applied and Environmental Microbiology. 76(11). 3462–3466. 177 indexed citations
12.
Way, Jeffrey C. & Michael Super. (2008). The potential for cancer combination therapy with multi-targeted, single-protein pharmaceuticals. Expert Opinion on Drug Discovery. 3(2). 147–152. 1 indexed citations
13.
Silver, Pamela A. & Jeffrey C. Way. (2007). Molecular Systems Biology in Drug Development. Clinical Pharmacology & Therapeutics. 82(5). 586–590. 10 indexed citations
14.
Way, Jeffrey C., Scott Lauder, Beatrice Brunkhorst, et al.. (2005). Improvement of Fc–erythropoietin structure and pharmacokinetics by modification at a disulfide bond. Protein Engineering Design and Selection. 18(3). 111–118. 28 indexed citations
15.
Way, Jeffrey C.. (2000). Covalent modification as a strategy to block protein–protein interactions with small-molecule drugs. Current Opinion in Chemical Biology. 4(1). 40–46. 38 indexed citations
16.
Way, Jeffrey C., et al.. (1996). Establishment and cost analysis of an office surgical suite.. Europe PMC (PubMed Central). 39(5). 379–83. 3 indexed citations
17.
Wang, Lili & Jeffrey C. Way. (1996). Promoter sequences for the establishment of mec-3 expression in the nematode Caenorhabditis elegans. Mechanisms of Development. 56(1-2). 183–196. 6 indexed citations
18.
Wang, Lili & Jeffrey C. Way. (1996). Activation of the mec-3 promoter in two classes of stereotyped lineages in Caenorhabditis elegans. Mechanisms of Development. 56(1-2). 165–181. 4 indexed citations
19.
Silver, Pamela A. & Jeffrey C. Way. (1993). Eukaryotic DnaJ homologs and the specificity of Hsp70 activity. Cell. 74(1). 5–6. 205 indexed citations
20.
Way, Jeffrey C., et al.. (1990). The behavioral genetics ofCaenorhabditis elegans. Behavior Genetics. 20(2). 169–189. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026